Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 56

1.

What are the mechanisms that support healthcare professionals to adopt assisted decision-making practice? A rapid realist review.

Davies C, Fattori F, O'Donnell D, Donnelly S, Ní Shé É, O Shea M, Prihodova L, Gleeson C, Flynn Á, Rock B, Grogan J, O'Brien M, O'Hanlon S, Cooney MT, Tighe M, Kroll T.

BMC Health Serv Res. 2019 Dec 12;19(1):960. doi: 10.1186/s12913-019-4802-x.

2.

Using geographic information systems to map older people's emergency department attendance for future health planning.

O'Mahony E, Ní Shé É, Bailey J, Mannan H, McAuliffe E, Ryan J, Cronin J, Cooney MT.

Emerg Med J. 2019 Dec;36(12):748-753. doi: 10.1136/emermed-2018-207952. Epub 2019 Nov 2.

3.

World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions.

WHO CVD Risk Chart Working Group.

Lancet Glob Health. 2019 Oct;7(10):e1332-e1345. doi: 10.1016/S2214-109X(19)30318-3. Epub 2019 Sep 2.

4.

Determinants of coronary artery disease risk factor management across three world regions.

Zhao M, Graham I, Cooney MT, Grobbee DE, Vaartjes I, Klipstein-Grobusch K.

Heart Asia. 2019 Mar 8;11(1):e011112. doi: 10.1136/heartasia-2018-011112. eCollection 2019.

5.

The challenges of using the Hospital Frailty Risk Score.

O'Caoimh R, Cooney MT, Cooke J, O'Shea D.

Lancet. 2019 Dec 22;392(10165):2693. doi: 10.1016/S0140-6736(18)32424-3. No abstract available.

PMID:
30587362
6.

Delaying and reversing frailty: a systematic review of primary care interventions.

Travers J, Romero-Ortuno R, Bailey J, Cooney MT.

Br J Gen Pract. 2019 Jan;69(678):e61-e69. doi: 10.3399/bjgp18X700241. Epub 2018 Dec 3.

PMID:
30510094
7.

SURF-COPD: the recording of cardiovascular risk in patients with chronic lung disease.

Dudina A, Lane S, Butler M, Cooney MT, Graham I.

QJM. 2018 May 1;111(5):303-306. doi: 10.1093/qjmed/hcy028.

PMID:
29432601
8.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Monique Verschuren WM, Vlachopoulos C, Wood DA, Luis Zamorano J; Additional Contributor, Cooney MT.

Rev Esp Cardiol (Engl Ed). 2017 Feb;70(2):115. doi: 10.1016/j.rec.2017.01.002. English, Spanish. No abstract available.

PMID:
29389351
9.

Undertaking a Collaborative Rapid Realist Review to Investigate What Works in the Successful Implementation of a Frail Older Person's Pathway.

Shé ÉN, Keogan F, McAuliffe E, O'Shea D, McCarthy M, McNamara R, Cooney MT.

Int J Environ Res Public Health. 2018 Jan 25;15(2). pii: E199. doi: 10.3390/ijerph15020199. Review.

10.

[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM.

G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821. Italian. No abstract available.

PMID:
28714997
11.

An evaluation of the performance of SCORE Sweden 2015 in estimating cardiovascular risk: The Northern Sweden MONICA Study 1999-2014.

Karjalainen T, Adiels M, Björck L, Cooney MT, Graham I, Perk J, Rosengren A, Söderberg S, Eliasson M.

Eur J Prev Cardiol. 2017 Jan;24(1):103-110. Epub 2016 Oct 5.

PMID:
27708071
12.

2016 European Guidelines on cardiovascular disease prevention in clinical practice.

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Richard Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Monique Verschuren WM.

Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):939. doi: 10.1016/j.rec.2016.09.009. English, Spanish. No abstract available.

PMID:
27692125
13.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members:, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, Bart van der Worp H, van Dis I, Verschuren WMM.

Atherosclerosis. 2016 Sep;252:207-274. doi: 10.1016/j.atherosclerosis.2016.05.037. No abstract available.

PMID:
27664503
14.

2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.

Catapano AL, Graham I, De Backer G, Wiklund O, Chapman MJ, Drexel H, Hoes AW, Jennings CS, Landmesser U, Pedersen TR, Reiner Ž, Riccardi G, Taskinen MR, Tokgozoglu L, Verschuren WMM, Vlachopoulos C, Wood DA, Zamorano JL, Cooney MT; ESC Scientific Document Group.

Eur Heart J. 2016 Oct 14;37(39):2999-3058. doi: 10.1093/eurheartj/ehw272. Epub 2016 Aug 27. No abstract available.

15.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors/Task Force Members, Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FD, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WM; Additional Contributor: Simone Binno (Italy); Document Reviewers:, De Backer G, Roffi M, Aboyans V, Bachl N, Bueno H, Carerj S, Cho L, Cox J, De Sutter J, Egidi G, Fisher M, Fitzsimons D, Franco OH, Guenoun M, Jennings C, Jug B, Kirchhof P, Kotseva K, Lip GY, Mach F, Mancia G, Bermudo FM, Mezzani A, Niessner A, Ponikowski P, Rauch B, Rydén L, Stauder A, Turc G, Wiklund O, Windecker S, Zamorano JL.

Eur J Prev Cardiol. 2016 Jul;23(11):NP1-NP96. doi: 10.1177/2047487316653709. Epub 2016 Jun 27. No abstract available.

PMID:
27353126
16.

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group.

Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. No abstract available.

17.

Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.

Zhao M, Cooney MT, Klipstein-Grobusch K, Vaartjes I, De Bacquer D, De Sutter J, Reiner Ž, Prescott E, Faggiano P, Vanuzzo D, AlFaleh H, Menown IB, Gait D, Posogova N, Sheu WH, Zhao D, Zuo H, Grobbee DE, Graham IM.

Eur J Prev Cardiol. 2016 Jul;23(11):1202-10. doi: 10.1177/2047487316647827. Epub 2016 Apr 26.

PMID:
27118362
18.

Cost effectiveness of inpatient rehabilitation in patients with brain injury.

Cooney MT, Carroll Á.

Clin Med (Lond). 2016 Apr;16(2):109-13. doi: 10.7861/clinmedicine.16-2-109.

19.

Improvement in the estimation of cardiovascular risk by carotid intima-medial thickness: A report from the Dublin Cardiohealth station study.

Cooney M, Cooney MT, Maher V, Khan B, Leong T, Graham I.

Prev Med Rep. 2015 Aug 13;2:725-9. doi: 10.1016/j.pmedr.2015.08.004. eCollection 2015.

20.

Cardiovascular risk estimation in older persons: SCORE O.P.

Cooney MT, Selmer R, Lindman A, Tverdal A, Menotti A, Thomsen T, DeBacker G, De Bacquer D, Tell GS, Njolstad I, Graham IM; SCORE and CONOR investigators.

Eur J Prev Cardiol. 2016 Jul;23(10):1093-103. doi: 10.1177/2047487315588390. Epub 2015 Jun 3.

PMID:
26040999
21.

Acute post-stroke blood pressure relative to premorbid levels in intracerebral haemorrhage versus major ischaemic stroke: a population-based study.

Fischer U, Cooney MT, Bull LM, Silver LE, Chalmers J, Anderson CS, Mehta Z, Rothwell PM.

Lancet Neurol. 2014 Apr;13(4):374-84. doi: 10.1016/S1474-4422(14)70031-6. Epub 2014 Feb 28.

22.

Risks in estimating risk.

Graham IM, Cooney MT.

Eur Heart J. 2014 Mar;35(9):537-9. doi: 10.1093/eurheartj/eht286. Epub 2013 Nov 7. No abstract available.

PMID:
24204012
23.

Frequent inaccuracies in ABCD2 scoring in non-stroke specialists' referrals to a daily Rapid Access Stroke Prevention service.

Bradley D, Cronin S, Kinsella JA, Tobin WO, Mahon C, O'Brien M, Lonergan R, Cooney MT, Kennelly S, Collins DR, O'Neill D, Coughlan T, Smyth S, McCabe DJ.

J Neurol Sci. 2013 Sep 15;332(1-2):30-4. doi: 10.1016/j.jns.2013.05.030. Epub 2013 Jul 17.

PMID:
23871489
24.

Residual risk of cardiovascular mortality in patients with coronary heart disease: the EUROASPIRE risk categories.

De Bacquer D, Dallongeville J, Kotseva K, Cooney MT, Pajak A, Deckers JW, Mayer O, Vanuzzo D, Lehto S, Fras Z, Östor E, Ambrosio GB, De Backer G, Wood D, Keil U, Sans S, Graham I, Pyörälä K.

Int J Cardiol. 2013 Sep 30;168(2):910-4. doi: 10.1016/j.ijcard.2012.10.051. Epub 2012 Nov 14.

PMID:
23157810
25.

SURF - SUrvey of Risk Factor management: first report of an international audit.

Cooney M, Reiner Z, Sheu W, Ryden L, Sutter Jd, De Bacquer D, DeBacker G, Mithal A, Chung N, Lim Y, Dudina A, Reynolds A, Dunney K, Graham I; SURF investigators; Prevention, Epidemiology and Population Science Section of the European Association for Cardiovascular Prevention and Rehabilitation.

Eur J Prev Cardiol. 2014 Jul;21(7):813-22. doi: 10.1177/2047487312467870. Epub 2012 Nov 12.

PMID:
23147276
26.

Dyslipidemias in the prevention of cardiovascular disease: risks and causality.

Graham I, Cooney MT, Bradley D, Dudina A, Reiner Z.

Curr Cardiol Rep. 2012 Dec;14(6):709-20. doi: 10.1007/s11886-012-0313-7. Review.

PMID:
22965836
27.

Do novel biomarkers add to existing scores of total cardiovascular risk?

De Backer G, Graham I, Cooney MT.

Eur J Prev Cardiol. 2012 Aug;19(2 Suppl):14-7. doi: 10.1177/2047487312448988. Review.

PMID:
22801065
28.

Cardiovascular risk age: concepts and practicalities.

Cooney MT, Vartiainen E, Laatikainen T, De Bacquer D, McGorrian C, Dudina A, Graham I; SCORE and FINRISK investigators.

Heart. 2012 Jun;98(12):941-6. doi: 10.1136/heartjnl-2011-301478.

PMID:
22626902
29.

A simple multiplier to calculate the impact of HDL cholesterol on cardiovascular risk estimation using SCORE.

Descamps OS, Cooney MT, De Backer G, Graham I.

Atherosclerosis. 2012 Jun;222(2):564-6. doi: 10.1016/j.atherosclerosis.2012.03.035. Epub 2012 Apr 7.

PMID:
22560327
30.

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvänne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG).

Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3. No abstract available. Erratum in: Eur Heart J. 2012 Sep;33(17):2126.

PMID:
22555213
31.

Determinants of risk factor control in subjects with coronary heart disease: a report from the EUROASPIRE III investigators.

Cooney MT, Kotseva K, Dudina A, De Backer G, Wood D, Graham I.

Eur J Prev Cardiol. 2013 Aug;20(4):686-91. doi: 10.1177/2047487312445562. Epub 2012 Apr 18.

PMID:
22514212
32.

'I'm just short for my weight, doctor': body weight and risk.

Graham I, Dudina A, Cooney MT.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):728-30. doi: 10.1177/1741826711417333. No abstract available.

PMID:
21945918
33.

Total cardiovascular disease risk assessment: a review.

Cooney MT, Cooney HC, Dudina A, Graham IM.

Curr Opin Cardiol. 2011 Sep;26(5):429-37. doi: 10.1097/HCO.0b013e3283499f06. Review.

PMID:
21822139
34.

Relationships between body mass index, cardiovascular mortality, and risk factors: a report from the SCORE investigators.

Dudina A, Cooney MT, Bacquer DD, Backer GD, Ducimetière P, Jousilahti P, Keil U, Menotti A, Njølstad I, Oganov R, Sans S, Thomsen T, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Conroy R, Fitzgerald A, Graham I; SCORE investigators.

Eur J Cardiovasc Prev Rehabil. 2011 Oct;18(5):731-42. doi: 10.1177/1741826711412039. Epub 2011 Jun 3.

PMID:
21642320
35.

Integrin α(IIb)β₃ exists in an activated state in subjects with elevated plasma homocysteine levels.

McGarrigle SA, O'Neill S, Walsh GM, Moran N, Graham IM, Cooney MT, Monavari A, Mayne P, Collins P.

Platelets. 2011;22(1):65-73. doi: 10.3109/09537104.2010.512646. Epub 2010 Dec 6.

PMID:
21133649
36.

Assessment of cardiovascular risk.

Cooney MT, Cooney HC, Dudina A, Graham IM.

Curr Hypertens Rep. 2010 Oct;12(5):384-93. doi: 10.1007/s11906-010-0143-1. Review.

PMID:
20838940
37.

Simplifying cardiovascular risk estimation using resting heart rate.

Cooney MT, Vartiainen E, Laatikainen T, Joulevi A, Dudina A, Graham I.

Eur Heart J. 2010 Sep;31(17):2141-7. doi: 10.1093/eurheartj/ehq164. Epub 2010 Jul 23.

PMID:
20657020
38.

Cardiovascular risk-estimation systems in primary prevention: do they differ? Do they make a difference? Can we see the future?

Cooney MT, Dudina A, D'Agostino R, Graham IM.

Circulation. 2010 Jul 20;122(3):300-10. doi: 10.1161/CIRCULATIONAHA.109.852756. Review. No abstract available.

PMID:
20644026
39.

Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women.

Cooney MT, Vartiainen E, Laatikainen T, Juolevi A, Dudina A, Graham IM.

Am Heart J. 2010 Apr;159(4):612-619.e3. doi: 10.1016/j.ahj.2009.12.029. Erratum in: Am Heart J. 2010 Jul;160(1):208. Laakitainen, Tinna [corrected to Laatikainen, Tiina].

PMID:
20362720
40.

Italian cardiovascular mortality charts of the CUORE project: are they comparable with the SCORE charts?

Donfrancesco C, Palmieri L, Cooney MT, Vanuzzo D, Panico S, Cesana G, Ferrario M, Pilotto L, Graham IM, Giampaoli S.

Eur J Cardiovasc Prev Rehabil. 2010 Aug;17(4):403-9. doi: 10.1097/HJR.0b013e328334ea70.

PMID:
20351552
41.

Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians.

Cooney MT, Dudina AL, Graham IM.

J Am Coll Cardiol. 2009 Sep 29;54(14):1209-27. doi: 10.1016/j.jacc.2009.07.020. Review.

42.

Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies.

Cooney MT, Dudina A, Whincup P, Capewell S, Menotti A, Jousilahti P, Njølstad I, Oganov R, Thomsen T, Tverdal A, Wedel H, Wilhelmsen L, Graham I; SCORE Investigators.

Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):541-9. doi: 10.1097/HJR.0b013e32832b38a1.

PMID:
19773660
43.

Chest pain in an 18-year-old man: "didn't I tell you I was sick?".

Dudina A, Leong T, Cooney MT, Foley B, Graham I.

Ir Med J. 2009 Jun;102(6):192. No abstract available.

PMID:
19722362
44.

What is my risk of developing cardiovascular disease?

Graham IM, Cooney MT, Dudina A, Squarta S.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16 Suppl 2:S2-7. doi: 10.1097/01.hjr.0000359226.50399.59. No abstract available.

PMID:
19675432
45.

Dyslipidemia therapy update: the importance of full lipid profile assessment.

Menown IB, Murtagh G, Maher V, Cooney MT, Graham IM, Tomkin G.

Adv Ther. 2009 Jul;26(7):711-8. doi: 10.1007/s12325-009-0052-3. Epub 2009 Jul 27. Review.

PMID:
19649582
46.

HeartScore predicts surrogate markers of cardiovascular disease in individuals aged below 40 years.

Cooney MT, Dudina A, Graham I; SCORE and HeartScore coordinating centres.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):513. doi: 10.1097/HJR.0b013e32832c2daa. No abstract available.

PMID:
19641423
47.

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.

Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I; SCORE Investigators.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):304-14. doi: 10.1097/HJR.0b013e3283213140.

PMID:
19609139
48.

EUROASPIRE (European Action on Secondary Prevention through Intervention to Reduce Events) III--a comparison of Irish and European results.

Cooney MT, Storey S, Taylor L, Dudina A, Hall M, Hemeryck L, Feely J, Graham I.

Ir Med J. 2009 Apr;102(4):113-6.

PMID:
19552291
49.

HDL cholesterol protects against cardiovascular disease in both genders, at all ages and at all levels of risk.

Cooney MT, Dudina A, De Bacquer D, Wilhelmsen L, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham IM; SCORE investigators.

Atherosclerosis. 2009 Oct;206(2):611-6. doi: 10.1016/j.atherosclerosis.2009.02.041. Epub 2009 Mar 19.

PMID:
19375079
50.

Homocysteine increases the risk associated with hyperlipidaemia.

Daly C, Fitzgerald AP, O'Callaghan P, Collins P, Cooney MT, Graham IM; COMAC Group.

Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):150-5. doi: 10.1097/HJR.0b013e32831e1185.

PMID:
19276985

Supplemental Content

Loading ...
Support Center